Wells Fargo & Company Centogene N.V. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.65 - $1.25 $5,355 - $10,298	-8,239 Reduced 4.01%	197,150 $139,000
Q4 2023 Feb 09, 2024	SELL	$1.02 - $1.47 $1,020 - $1,470	-1,000 Reduced 0.48%	205,389 $246,000
Q3 2023 Nov 13, 2023	BUY	$1.0 - $1.64 $188 - $308	188 Added 0.09%	206,389 $218,000
Q2 2023 Aug 15, 2023	SELL	$0.63 - $1.63 $118 - $306	-188 Reduced 0.09%	206,201 $309,000
Q1 2023 May 12, 2023	BUY	$0.65 - $1.43 $12,052 - $26,515	18,542 Added 9.87%	206,389 $134,000
Q4 2022 Feb 13, 2023	SELL	$0.72 - $1.28 $169,255 - $300,898	-235,077 Reduced 55.58%	187,847 $174,000
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.78 $50,865 - $127,393	45,825 Added 12.15%	422,924 $474,000
Q2 2022 Aug 12, 2022	BUY	$2.06 - $4.25 $180,214 - $371,802	87,483 Added 30.21%	377,099 $894,000
Q1 2022 May 16, 2022	BUY	$3.3 - $5.44 $352,730 - $581,470	106,888 Added 58.5%	289,616 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$4.56 - $10.56 $337,367 - $781,271	73,984 Added 68.04%	182,728 $955,000
Q3 2021 Nov 15, 2021	BUY	$9.9 - $11.72 $1.01 Million - $1.2 Million	101,996 Added 1511.5%	108,744 $1.2 Million
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.93 $125,612 - $180,063	-13,926 Reduced 67.36%	6,748 $70,000
Q1 2021 May 13, 2021	BUY	$10.56 - $13.94 $113,593 - $149,952	10,757 Added 108.47%	20,674 $250,000
Q4 2020 Feb 09, 2021	BUY	$9.44 - $13.3 $43,905 - $61,858	4,651 Added 88.32%	9,917 $107,000
Q3 2020 Nov 05, 2020	BUY	$9.3 - $25.16 $13,754 - $37,211	1,479 Added 39.05%	5,266 $50,000
Q2 2020 Aug 13, 2020	BUY	$15.99 - $22.88 $32,475 - $46,469	2,031 Added 115.66%	3,787 $87,000
Q1 2020 May 14, 2020	BUY	$9.76 - $23.8 $17,138 - $41,792	1,756 New	1,756 $35,000

Others Institutions Holding CNTG

# of Institutions

Shares Held

33.6K

Call Options Held

Put Options Held

View Full List

About Centogene N.V.

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

More about CNTG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account